Dmitry Genkin
Impact in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 4
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Immune cells in cancer 3
-
- Multiple Sclerosis Research Studies 4
- Co-authors
- I. V. Smirnov (8 shared papers)Alexander G. Gabibov (9 shared papers)Alexey A. Belogurov (8 shared papers)А. В. Степанов (6 shared papers)Н. А. Пономаренко (6 shared papers)Andrew Bacon (3 shared papers)I. I. Vorobiev (4 shared papers)George Tetz (3 shared papers)
- Journals
- Molecular Oncology (1 paper)Neurotherapeutics (1 paper)Recent Patents on Drug Delivery & Formulation (1 paper)Science Advances (1 paper)Molecular Immunology (1 paper)
- Partner nations
- RussiaUnited StatesFrance
In The Last Decade
Dmitry Genkin
15 papers receiving 362 citations
Peers
Comparison fields: 5 of 66
- Immunology 151
- Radiology, Nuclear Medicine and Imaging 69
- Immunology and Allergy 18
- Biotechnology 23
- Pharmaceutical Science 15
Countries citing papers authored by Dmitry Genkin
This map shows the geographic impact of Dmitry Genkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitry Genkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitry Genkin more than expected).
Fields of papers citing papers by Dmitry Genkin
This network shows the impact of papers produced by Dmitry Genkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitry Genkin. The network helps show where Dmitry Genkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Dmitry Genkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 78 | |
| 2 | 2013 | 55 | |
| 3 | 2012 | 49 | |
| 4 | 2009 | 40 | |
| 5 | 2016 | 34 | |
| 6 | 2016 | 25 | |
| 7 | 2018 | 21 | |
| 8 | 2015 | 14 | |
| 9 | 2018 | 11 | |
| 10 | 2012 | 10 | |
| 11 | 2015 | 10 | |
| 12 | 2002 | 8 | |
| 13 | 2012 | 6 | |
| 14 | 2020 | 2 | |
| 15 | 2024 | 1 |
About Dmitry Genkin
Dmitry Genkin is a scholar working on Immunology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pharmacology, having authored 15 papers that have together received 364 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Multiple Sclerosis Research Studies (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Immune cells in cancer (3 papers), HIV Research and Treatment (2 papers) and Pesticide Exposure and Toxicity (2 papers). The work is most often cited by research in Immunology (151 citations), Radiology, Nuclear Medicine and Imaging (69 citations), Immunology and Allergy (18 citations), Biotechnology (23 citations) and Pharmaceutical Science (15 citations). Dmitry Genkin has collaborated with scholars based in Russia, United States and France. Frequent co-authors include I. V. Smirnov, Alexander G. Gabibov, Alexey A. Belogurov, А. В. Степанов, Н. А. Пономаренко, Andrew Bacon, I. I. Vorobiev, George Tetz, Stanislav S. Terekhov and Yu Wang. Their work appears in journals such as Molecular Oncology, Neurotherapeutics, Recent Patents on Drug Delivery & Formulation, Science Advances and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.